NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NuGEN Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5333
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA and RNA, target capture, ChIP-Seq, and Methyl-Seq, Microarrays and qPCR, and bioinformatics and automation software solutions, among others. NuGen’s next generation technologies are used in the areas of cancer detection, infectious disease, liquid biopsy, agrigenomics, microbiomics and epigenetics, among others. The company markets its products through a network of distributors located across the US, Australia, the Netherlands, South Korea, Canada, China, Spain and Hong Kong, among others. It operates in San Carlos, the US and Leek, the Netherlands. NuGEN is headquartered in San Carlos, California, the US.

NuGEN Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NuGEN Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NuGEN Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
NuGEN Technologies Raises USD6.2 Million in Venture Financing 11
Partnerships 12
NuGEN Technologies Enters into Agreement with Cambridge Epigenetix 12
Acquisition 13
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 13
NuGEN Technologies Inc – Key Competitors 14
NuGEN Technologies Inc – Key Employees 15
NuGEN Technologies Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Legal and Regulatory 17
Aug 13, 2018: NuGEN and KeyGene announce settlement in declaratory judgment lawsuit 17
Product News 18
Oct 02, 2017: NuGEN Introduces Unique Indexing Solutions for Illumina’s High Capacity Sequencing Platforms 18
Other Significant Developments 19
Jan 31, 2017: NuGEN Continues with Investment Across Worldwide Territories 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NuGEN Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NuGEN Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
NuGEN Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NuGEN Technologies Raises USD6.2 Million in Venture Financing 11
NuGEN Technologies Enters into Agreement with Cambridge Epigenetix 12
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 13
NuGEN Technologies Inc, Key Competitors 14
NuGEN Technologies Inc, Key Employees 15

List of Figures
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NuGEN Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banca Dello Stato Del Cantone Ticino:企業の戦略・SWOT・財務分析
    Banca Dello Stato Del Cantone Ticino - Strategy, SWOT and Corporate Finance Report Summary Banca Dello Stato Del Cantone Ticino - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Breville Group Limited (BRG):企業の財務・戦略的SWOT分析
    Breville Group Limited (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Aveng Ltd (AEG):企業の財務・戦略的SWOT分析
    Aveng Ltd (AEG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • SPR Therapeutics LLC:製品パイプライン分析
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It also provides pe …
  • Oasis Petroleum Inc. (OAS)-石油・ガス分野:企業M&A・提携分析
    Summary Oasis Petroleum Inc. (Oasis Petroleum) is an independent exploration and production company. It focuses on the acquisition and development of unconventional oil and natural gas resources. The company operates in the Williston Basin in North Dakota and Montana, which consists of project areas …
  • Sharp HealthCare:企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Immunicom Inc:医療機器:M&Aディール及び事業提携情報
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company that develops non-pharmaceutical therapies for oncology and autoimmune diseases. The company offers immune inhibitors that play a key role in protecting tumors from the body’s natural immune mechanisms. It proprietary Immunophere …
  • Uponor Oyj:企業の戦略・SWOT・財務情報
    Uponor Oyj - Strategy, SWOT and Corporate Finance Report Summary Uponor Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Accredo Health Group Inc:企業の戦略的SWOT分析
    Accredo Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Whole Foods Market Inc:企業のM&A・事業提携・投資動向
    Whole Foods Market Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Whole Foods Market Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sime Darby Berhad:戦略・SWOT・企業財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …
  • Crown Holdings Inc:戦略・SWOT・企業財務分析
    Crown Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Crown Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fnm Spa
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rizzani De Eccher S.P.A.
    Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Premier Foods plc (PFD):企業の財務・戦略的SWOT分析
    Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Enmax Corporation:電力:M&Aディール及び事業提携情報
    Summary ENMAX Corporation (ENMAX), a subsidiary of City of Calgary, is a vertically integrated energy utility. It generates, transmits and distributes electricity; supplies natural gas; and provides value-added services. Through its subsidiaries, the company undertakes deregulated electricity genera …
  • UniQuest Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆